Retension Pharmaceuticals (RTSN) vs TRex Bio (TRXB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 12, 2026.
Summary
TRex Bio is the larger company by market cap ($385.1 million vs $89.2 million), about 4.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | RTSN | TRXB |
|---|---|---|
| Share price | $11.32 | $14.03 |
| Market cap | $89.22M | $385.06M |
| 1-day change | +7.50% | +0.21% |
| EPS (TTM) | $-2.61 | $-2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.79 | $15.50 |
| 52-week low | $9.66 | $13.50 |
| Distance from 52-week high | -3.99% | -9.48% |
| Average volume | 789.20K | 1.26M |
| Shares outstanding | 7.88M | 27.45M |
| Employees | 12 | 60 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TRex Bio is about 4.3 times larger than Retension Pharmaceuticals by market value ($385.06M vs $89.22M).
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About TRex Bio
TRXB stock →TRex Bio, Inc. operates as a clinical-stage biopharmaceutical company that engages in discovery and development of immunoregulatory medicines.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 60 employees
RTSN vs TRXB FAQ
Which is bigger, Retension Pharmaceuticals or TRex Bio?
TRex Bio (TRXB) is larger, with a market capitalization of $385.06M compared with $89.22M for Retension Pharmaceuticals (RTSN).
Are Retension Pharmaceuticals and TRex Bio in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for Retension Pharmaceuticals and Biotechnology: Biological Products (No Diagnostic Substances) for TRex Bio.